Frequency Therapeutics Future Growth
Future criteria checks 0/6
Frequency Therapeutics's earnings are forecast to decline at 4.7% per annum. EPS is expected to grow by 10.4% per annum.
Key information
-4.7%
Earnings growth rate
10.4%
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 26 Sep 2023 |
Recent future growth updates
Recent updates
Is Frequency Therapeutics (NASDAQ:FREQ) Weighed On By Its Debt Load?
Jan 01
Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?
Jan 19Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are Reducing Their Forecasts For This Year
Aug 18Health Check: How Prudently Does Frequency Therapeutics (NASDAQ:FREQ) Use Debt?
Jul 31Frequency Therapeutics (FREQ) Investor Presentation - Slideshow
Jun 18Frequency Therapeutics: A Look At What's Next After A Disappointing Data Readout
Apr 21Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are More Bearish Than They Used To Be
Apr 04We're Not Worried About Frequency Therapeutics' (NASDAQ:FREQ) Cash Burn
Mar 15If You Had Bought Frequency Therapeutics (NASDAQ:FREQ) Shares A Year Ago You'd Have Earned 55% Returns
Jan 22Have Insiders Sold Frequency Therapeutics, Inc. (NASDAQ:FREQ) Shares Recently?
Dec 27Frequency Therapeutics to host investor event in early January next year
Dec 18How Much Are Frequency Therapeutics, Inc. (NASDAQ:FREQ) Insiders Taking Off The Table?
Dec 10Frequency Therapeutics, Inc. (NASDAQ:FREQ) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 19Frequency Therapeutics EPS beats by $0.16, beats on revenue
Nov 16Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -57 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -44 | N/A | N/A | 2 |
| 12/31/2023 | N/A | -50 | N/A | N/A | 2 |
| 9/30/2023 | N/A | -59 | -43 | -43 | N/A |
| 6/30/2023 | N/A | -67 | -50 | -50 | N/A |
| 3/31/2023 | N/A | -78 | -55 | -55 | N/A |
| 12/31/2022 | N/A | -82 | -58 | -58 | N/A |
| 9/30/2022 | N/A | -86 | -61 | -61 | N/A |
| 6/30/2022 | N/A | -91 | -64 | -64 | N/A |
| 3/31/2022 | 9 | -88 | -70 | -68 | N/A |
| 12/31/2021 | 14 | -85 | -79 | -76 | N/A |
| 9/30/2021 | 24 | -73 | -80 | -73 | N/A |
| 6/30/2021 | 35 | -54 | -77 | -69 | N/A |
| 3/31/2021 | 34 | -42 | -68 | -61 | N/A |
| 12/31/2020 | 37 | -27 | -52 | -45 | N/A |
| 9/30/2020 | 32 | -22 | -63 | -60 | N/A |
| 6/30/2020 | 45 | -18 | 23 | 25 | N/A |
| 3/31/2020 | 36 | -19 | 30 | 31 | N/A |
| 12/31/2019 | 29 | -20 | 33 | 34 | N/A |
| 9/30/2019 | 24 | -20 | 58 | 59 | N/A |
| 6/30/2019 | N/A | -23 | -20 | -19 | N/A |
| 3/31/2019 | N/A | -21 | -20 | -19 | N/A |
| 12/31/2018 | N/A | -19 | -17 | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FREQ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FREQ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FREQ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if FREQ's revenue is forecast to grow faster than the US market.
High Growth Revenue: FREQ is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FREQ's Return on Equity is forecast to be high in 3 years time